8329 logo

Shenzhen Neptunus Interlong Bio-technique Company Limited Stock Price

SEHK:8329 Community·HK$251.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

8329 Share Price Performance

HK$0.15
0.02 (13.74%)
HK$0.15
0.02 (13.74%)
Price HK$0.15

8329 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet with moderate risk.

5 Risks
0 Rewards

Shenzhen Neptunus Interlong Bio-technique Company Limited Key Details

CN¥993.1m

Revenue

CN¥704.4m

Cost of Revenue

CN¥288.7m

Gross Profit

CN¥282.6m

Other Expenses

CN¥6.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.0037
29.07%
0.62%
12.8%
View Full Analysis

About 8329

Founded
2002
Employees
1474
CEO
n/a
WebsiteView website
www.interlong.com

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China. The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental disorders. It also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology business. Shenzhen Neptunus Interlong Bio-technique Company Limited was incorporated in 2002 and is based in Quarry Bay, Hong Kong. Shenzhen Neptunus Interlong Bio-technique Company Limited is a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.

Recent 8329 News & Updates

Recent updates

No updates